202202 bcvcVersion of RecordOthersFunding was obtained from Shenzhen Science and Technology Innovation Commission: Research on Early Warning Model of Drug-induced Liver Injury in Tuberculosis Patients Based on Machine Learning (award# JCYJ20190809153201668) and the Sanming Project of Medicine in Shenzhen (award# SZSM201603029).Publishe
Background: Anti-tuberculous (TB) medications are common causes of drug-induced liver injury (DILI)....
A major challenge in drug development is safety and toxicity concerns due to drug side effects. One ...
Drug-induced liver injury (DILI) has been the single most frequent cause of safety-related drug mark...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
<p><strong>Introduction and objectives:</strong></p><p>Tuberculosis (TB) still remains a major healt...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
Background: Tuberculosis (TB) is a major global health problem, mainly in developing countries. Desp...
202208 bckwRGCOthersOthers: General Research Fund (15205119);Shenzhen Science and Technology Innovat...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
ObjectiveTo investigate the clinical features of liver injury induced by anti-tuberculosis drugs and...
Abstract Tuberculosis (TB) is a killer disease, and its root can be traced to Mycobacterium tubercu...
Drug discovery is a costly process which usually takes more than 10 years and billions of dollars fo...
Background: Anti-tuberculous (TB) medications are common causes of drug-induced liver injury (DILI)....
A major challenge in drug development is safety and toxicity concerns due to drug side effects. One ...
Drug-induced liver injury (DILI) has been the single most frequent cause of safety-related drug mark...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
<p><strong>Introduction and objectives:</strong></p><p>Tuberculosis (TB) still remains a major healt...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
Background: Tuberculosis (TB) is a major global health problem, mainly in developing countries. Desp...
202208 bckwRGCOthersOthers: General Research Fund (15205119);Shenzhen Science and Technology Innovat...
BackgroundAnti-tuberculosis drug-induced liver injury (ATB-DILI) is one of the most common adverse r...
ObjectiveTo investigate the clinical features of liver injury induced by anti-tuberculosis drugs and...
Abstract Tuberculosis (TB) is a killer disease, and its root can be traced to Mycobacterium tubercu...
Drug discovery is a costly process which usually takes more than 10 years and billions of dollars fo...
Background: Anti-tuberculous (TB) medications are common causes of drug-induced liver injury (DILI)....
A major challenge in drug development is safety and toxicity concerns due to drug side effects. One ...
Drug-induced liver injury (DILI) has been the single most frequent cause of safety-related drug mark...